Skip to main content
Equibles

Swiss National Bank

Bank

Position in LGND — Ligand Pharmaceuticals Inc

CIK 1582202 ZURICH, V8
Back to LGND Full portfolio

Position in LGND

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$12,327,510
+$4,561,125 QoQ
Shares Held
39,000
+0.3% QoQ
Ownership
0.196%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#78
of 415 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LGND Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Swiss National Bank holds $1,800,323,370 across 152 Biotechnology names. LGND ranks #27 (0.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 717,440 $356,373,971
2 REGN
Regeneron Pharmaceuticals, Inc.
 293,020 $182,709,690
3 ALNY
Alnylam Pharmaceuticals, Inc.
 374,080 $112,609,302
4 RVMD
Revolution Medicines, Inc.
 456,331 $85,461,669
5 RPRX
Royalty Pharma plc
 1,159,800 $65,029,986
6 INSM
INSMED Inc
 593,512 $63,280,249
7 INCY
Incyte Corp
 476,874 $54,058,436
8 MRNA
Moderna, Inc.
 679,900 $47,613,397

All Filings in LGND

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,327,510 39,000
2026-03-31 $7,766,385 38,900
2025-12-31 $7,298,102 38,600
2025-09-30 $6,625,036 37,400
2025-06-30 $4,183,424 36,800
2025-03-31 $3,848,124 36,600
2024-12-31 $3,857,400 36,000
2024-09-30 $3,513,159 35,100
2024-06-30 $2,789,006 33,100
2024-03-31 $2,390,370 32,700
2023-12-31 $2,321,150 32,500
2023-09-30 $2,163,112 36,100
2023-06-30 $2,545,130 35,300
2023-03-31 $2,684,940 36,500
2022-12-31 $2,718,760 40,700
2022-09-30 $3,444,398 40,000
2022-06-30 $3,524,187 39,500
2022-03-31 $4,443,356 39,500
2021-12-31 $5,668,680 36,700
2021-09-30 $5,126,973 36,800
2021-06-30 $4,801,554 36,600
2021-03-31 $5,610,158 36,800
2020-12-31 $3,619,978 36,400
2020-09-30 $3,469,647 36,400
2020-06-30 $4,116,078 36,800
2020-03-31 $2,479,749 34,100